World's Best Scientists 2026 revealed!

D-Index & Metrics

Biology and Biochemistry

D-Index
54
Citations
8236
World Ranking
15832
National Ranking
1242

Overview

John Kay is affiliated with Cardiff University in the United Kingdom. Their research primarily falls within the field of Medicine, with a focus on Endocrinology, Diabetes and Metabolism, Physiology, Surgery, and Molecular Biology as subfields. The scientist's work contributes to several topics including Diabetes Treatment and Management, Diet and Metabolism Studies, Lipoproteins and Cardiovascular Health, and the intersections of Metabolism, Diabetes, and Cancer.

Recent publications by John Kay include:

  • The Real-World Costs of GLP-1 Receptor Agonist Treatment, 2025, bioRxiv (Cold Spring Harbor Laboratory)
  • The Real-World Clinical Benefits of GLP-1 Receptor Agonist Treatment, 2025, bioRxiv (Cold Spring Harbor Laboratory)

These papers reflect a particular interest in GLP-1 receptor agonists and their clinical and economic impact, published in the preprint server bioRxiv, a frequent venue for their work.

John Kay collaborates often with a set of co-authors including:

  • David E. Wennberg
  • Henriette Coetzer
  • Amy Marr
  • Caroline Margiotta
  • Rafat S. Hashmi

The recurring partnerships suggest ongoing collaborative research efforts particularly centered on endocrinology and metabolism topics.

The scientist has contributed five publications in Medicine, with specific focus as noted across the subfields and main topics. The consistency of venues such as bioRxiv indicates ongoing dissemination of early findings in the field.

Best Publications

  • Aspartic proteases of Plasmodium falciparum and other parasitic protozoa as drug targets

    Graham H. Coombs;Daniel E. Goldberg;Michael Klemba;Colin Berry

  • The V3 loops of the HIV-1 and HIV-2 surface glycoproteins contain proteolytic cleavage sites: a possible function in viral fusion?

    Gary J. Clements;Molly J. Price-Jones;Paul E. Stephens;Christopher Sutton

  • Antigen processing for presentation by class II major histocompatibility complex requires cleavage by cathepsin E.

    Bennett K;Levine T;Ellis Js;Peanasky Rj

  • Effective blocking of HIV-1 proteinase activity by characteristic inhibitors of aspartic proteinases.

    Anthony D. Richards;Ray Roberts;Ben M. Dunn;Mary C. Graves

  • Aspartic proteinases and their inhibitors.

    John Kay

  • A systematic series of synthetic chromophoric substrates for aspartic proteinases.

    B M Dunn;M Jimenez;B F Parten;M J Valler

  • Immunolocalization of cathepsin D in normal and neoplastic human tissues.

    W A Reid;M J Valler;J Kay

  • Viral proteinases: weakness in strength.

    John Kay;Ben M. Dunn

  • High resolution X-ray analyses of renin inhibitor-aspartic proteinase complexes

    S. I. Foundling;J. Cooper;F. E. Watson;A. Cleasby

  • Sequence, expression and modeled structure of an aspartic proteinase from the human malaria parasite Plasmodium falciparum.

    John B. Dame;G.Roman Reddy;Charles A. Yowell;Ben M. Dunn

  • Different requirements for productive interaction between the active site of HIV-1 proteinase and substrates containing -hydrophobic*hydrophobic- or -aromatic*pro- cleavage sites.

    Jonathan T. Griffiths;Lowri H. Phylip;Jan Konvalinka;Petr Strop

  • High level expression and characterisation of Plasmepsin II, an aspartic proteinase from Plasmodium falciparum

    Jeffrey Hill;Lorraine Tyas;Lowri H. Phylip;John Kay

  • Expression and characterisation of plasmepsin I from Plasmodium falciparum.

    Richard P. Moon;Lorraine Tyas;Ulrich Certa;Katharina Rupp

  • Presence and possible significance of immunocytochemically demonstrable metallothionein over-expression in primary invasive ductal carcinoma of the breast.

    K. W. Schmid;I. O. Ellis;Julia Margaret Wendy Gee;Barbara M. Darke

  • Slow moving proteinase: Isolation, characterization, and immunohistochemical localization in gastric mucosa

    I.M. Samloff;R.T. Taggart;T. Shiraishi;T. Branch

  • The aspartic proteinase from Saccharomyces cerevisiae folds its own inhibitor into a helix.

    Mi Li;Lowri H. Phylip;Wendy E. Lees;Jakob R. Winther

  • The Botrytis cinerea aspartic proteinase family

    Arjen ten Have;José J. Espino;Ester Dekkers;Steven C. Van Sluyter;Steven C. Van Sluyter

  • A plant metallothionein produced in E. coli.

    Peter Kille;Dennis R. Winge;John L. Harwood;John Kay

  • A comparison of the cadmium-binding proteins isolated from the posterior alimentary canal of the earthworms Dendrodrilus rubidus and Lumbricus rubellus

    J.E. Morgan;C.G. Norey;A.J. Morgan;J. Kay

  • A distinct member of the aspartic proteinase gene family from the human malaria parasite Plasmodium falciparum

    Colin Berry;Michelle J Humphreys;Philip Matharu;Rachel Granger

Frequent Co-Authors

Ben M. Dunn
Ben M. Dunn University of Florida
Peter Kille
Peter Kille Cardiff University
Colin Berry
Colin Berry University of Glasgow
Robert J. Beynon
Robert J. Beynon University of Liverpool
Alexander Wlodawer
Alexander Wlodawer National Institutes of Health
Tom L. Blundell
Tom L. Blundell University of Cambridge
Jan Konvalinka
Jan Konvalinka Czech Academy of Sciences
Jan A. L. van Kan
Jan A. L. van Kan Wageningen University & Research
Clemente Capasso
Clemente Capasso National Academies of Sciences, Engineering, and Medicine
John L. Harwood
John L. Harwood Cardiff University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Best Scientists Citing John Kay